CH675834A5 - - Google Patents

Download PDF

Info

Publication number
CH675834A5
CH675834A5 CH1664/88A CH166488A CH675834A5 CH 675834 A5 CH675834 A5 CH 675834A5 CH 1664/88 A CH1664/88 A CH 1664/88A CH 166488 A CH166488 A CH 166488A CH 675834 A5 CH675834 A5 CH 675834A5
Authority
CH
Switzerland
Prior art keywords
day
smoking
pharmaceutical composition
milligrams
bromocriptine
Prior art date
Application number
CH1664/88A
Other languages
German (de)
English (en)
Inventor
Peter S Mueller
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH675834A5 publication Critical patent/CH675834A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH1664/88A 1987-05-07 1988-05-04 CH675834A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4775387A 1987-05-07 1987-05-07

Publications (1)

Publication Number Publication Date
CH675834A5 true CH675834A5 (xx) 1990-11-15

Family

ID=21950776

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1664/88A CH675834A5 (xx) 1987-05-07 1988-05-04

Country Status (13)

Country Link
JP (1) JPS63287723A (xx)
KR (1) KR880013556A (xx)
AU (1) AU622614B2 (xx)
CH (1) CH675834A5 (xx)
DE (1) DE3814521A1 (xx)
DK (1) DK245388A (xx)
FR (1) FR2614789B1 (xx)
GB (1) GB2204240B (xx)
IT (1) IT1219564B (xx)
NL (1) NL8801171A (xx)
PH (1) PH25495A (xx)
SE (1) SE8801708L (xx)
ZA (1) ZA883237B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR861128B (en) * 1985-05-06 1986-08-26 Sandoz Ag New use of dopamine agonists
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin

Also Published As

Publication number Publication date
DK245388A (da) 1988-11-08
ZA883237B (en) 1990-01-31
JPS63287723A (ja) 1988-11-24
IT1219564B (it) 1990-05-18
DK245388D0 (da) 1988-05-05
FR2614789A1 (fr) 1988-11-10
PH25495A (en) 1991-07-24
SE8801708D0 (sv) 1988-05-05
FR2614789B1 (fr) 1991-10-18
GB2204240A (en) 1988-11-09
DE3814521A1 (de) 1988-11-17
SE8801708L (sv) 1988-11-08
AU1560588A (en) 1988-11-10
AU622614B2 (en) 1992-04-16
IT8847906A0 (it) 1988-05-03
GB2204240B (en) 1991-04-24
KR880013556A (ko) 1988-12-21
GB8810509D0 (en) 1988-06-08
NL8801171A (nl) 1988-12-01

Similar Documents

Publication Publication Date Title
AT401615B (de) Verwendung von speziellen 5ht3-antagonisten zur herstellung von arzneimitteln
DE69811378T2 (de) Zusammensetzungen zur behandlung von nikotinabhängigkeit, enthaltend mecamylamin und bupropion
DE69823520T2 (de) Noribogain zur behandlung von schmerzen und drogenabhängigkeit
DE69732189T3 (de) Formulation von 5-ht agonisten
HUT74920A (en) Improved nicotine lozenge and therapeutic method for smoking cessation
Young et al. Nicotine and bupropion share a similar discriminative stimulus effect
US4800204A (en) Method of controlling tobacco use
US5480651A (en) Composition and method for treating nicotine craving in smoking cessation
DE3023588A1 (de) Mittel zum abgewoehnen des rauchens und zum verlieren von uebergewicht
DE60017147T2 (de) Verwendung von gabab-rezeptor agonisten und deren pharmazeutisch akzeptierbaren derivate bei der therapie zur erhaltung von nikotinabstinenz bei nikotinabhängigen patienten
DE69634662T2 (de) Schmerzlindernde verwendung von n-l-alpha-aspartyl-l-phenylalanine-1-methylester
US5414005A (en) Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
CH675834A5 (xx)
DE69331008T2 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
DE3686097T2 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
US5880164A (en) Nicotine-free smoking material
EP1418908A1 (de) Verbindungen zur beseitigung und/oder linderung der anhedonie
WO1986001108A1 (fr) Composition pharmaceutique
EP0725640A1 (en) Use of lobeline for the treatment of nicotine withdrawal
ISBELL The newer analgesic drugs; their use and abuse
Kuhn et al. Pharmacology and hypnogenic properties of brotizolam in animals.
DE2513521A1 (de) Neue zusammensetzungen zur bekaempfung von giftstoffbedingten schaedlichen wirkungen und gewoehnungserscheinungen beim menschen
WO1990000896A1 (en) USE OF BENZO(g)QUINOLINES IN TREATMENT OF NICOTINE ADDICTION
Wade et al. First impressions of the use of meptazinol in general practice
DE10318714B4 (de) Wirkstoff-Kombinationen und Therapien zur Bekämpfung des Alkoholmissbrauches

Legal Events

Date Code Title Description
PUE Assignment

Owner name: PETER S. MUELLER

PL Patent ceased